Inj alymsys 10 mg
Products billed under this code include Alymsys.
Payment limit per 10 MG, by effective quarter, 2Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Alymsys.
Payment limit per 10 MG, by effective quarter, 2Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Alymsys | Amneal Pharmaceuticals, LLC | 70121-1754-01 | 10 | $799.82 |
| Alymsys | Amneal Pharmaceuticals, LLC | 70121-1755-01 | 40 | $3,199.28 |
| Alymsys | Valorum Biologics, LLC | 85006-1754-01 | 10 | $799.82 |
| Alymsys | Valorum Biologics, LLC | 85006-1755-01 | 40 | $3,199.28 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $79.982 | +$0.038 | 10 MG | Inj alymsys 10 mg | v1, posted September 17, 2026 |
| 3Q26 | $79.944 | +$28.355 | 10 MG | Inj alymsys 10 mg | v1, posted September 15, 2026 |
| 2Q26 | $51.589 | +$18.577 | 10 MG | Inj alymsys 10 mg | v1, posted September 15, 2026 |
| 1Q26 | $33.012 | −$4.806 | 10 MG | Inj alymsys 10 mg | v1, posted September 15, 2026 |
| 4Q25 | $37.818 | −$4.782 | 10 MG | Inj alymsys 10 mg | v1, posted September 8, 2026 |
| 3Q25 | $42.60 | −$3.454 | 10 MG | Inj alymsys 10 mg | v1, posted March 10, 2026 |
| 2Q25 | $46.054 | −$2.734 | 10 MG | Inj alymsys 10 mg | v1, posted March 10, 2026 |
| 1Q25 | $48.788 | +$0.086 | 10 MG | Inj alymsys 10 mg | v1, posted December 19, 2025 |
| 4Q24 | $48.702 | −$3.649 | 10 MG | Inj alymsys 10 mg | v1, posted June 11, 2025 |
| 3Q24 | $52.351 | −$3.035 | 10 MG | Inj alymsys 10 mg | v1, posted June 11, 2025 |
| 2Q24 | $55.386 | −$5.198 | 10 MG | Inj alymsys 10 mg | v1, posted March 11, 2025 |
| 1Q24 | $60.584 | −$3.332 | 10 MG | Inj alymsys 10 mg | v1, posted December 19, 2024 |
| 4Q23 | $63.916 | −$8.602 | 10 MG | Inj alymsys 10 mg | v1, posted October 10, 2024 |
| 3Q23 | $72.518 | −$1.19 | 10 MG | Inj alymsys 10 mg | v1, posted June 5, 2024 |
| 2Q23 | $73.708 | – | 10 MG | Inj alymsys 10 mg | v1, posted February 23, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.